In an analysis of 7-year follow-up data from the REASSURE study, Bertrand Tombal, MD, emphasized that the findings remain true to the study’s name—reassuring. The results show no significant increase in hematologic toxicity with Radium-223…
REASSURE Data Affirm Safety of Radium-223 in mCRPC, Underscore Need for Bone Protection
